Zymographic analysis of circulating and tissue forms of colon carcinoma gelatinase A (MMP-2) and B (MMP-9) separated by mono- and two-dimensional electrophoresis

Matrix Biology

Volumn 20, Issue 7, 2001, Pages 419-427

  Pucci Minafra, Ida ^a   Minafra, Salvatore ^a   La Rocca, Giampiero ^a   Barranca, Marilisa ^a   Fontana, Simona ^a   Alaimo, Giuseppina ^a   Okada, Yasunori ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Colon cancer; Matrix metalloproteinases; Second dimension zymography

Indexed keywords

GELATINASE A; GELATINASE B; ISOPROTEIN; PROTEIN; TISSUE EXTRACT;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PROCEDURES; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SERUM; TWO DIMENSIONAL ELECTROPHORESIS; ZYMOGRAPHY;

ADULT; COLONIC NEOPLASMS; DENSITOMETRY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME PRECURSORS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9;

EID: 0034752257     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(01)00146-9     Document Type: Article

References (25)

1. Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC
2. Tissue inhibitors of metalloproteinases: Evolution, structure and function
3. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion
4. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies
5. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy
6. Matrix metalloproteinas 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
7. Elevated plasma levels of matrix metalloproteinase-9 (92-kD type IV collagenase/gelatinase B) in hepatocellular carcinoma
8. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinoma
9. Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus
10. Matrix metalloprotease 2 (MMP2) and matrix metalloprotease 9 (MMP9) type IV collagenases in colorectal cancer
11. Tumor invasion: Role of the extracellular matrix
12. Involvement of extracellular matrix constituents in breast cancer
13. Wound healing, aiming for perfect skin regeneration
14. Matrix metalloproteinases
15. Expression and activity of MMPs and their regulators in ovarian cancer
16. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer
17. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties
18. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9
19. A new form of tumor and foetal collagen with laminin-binding property
20. Absence of regular α2(I) collagen chains in colon carcinoma biopsy fragments
21. Elevated levels of Mr 92,000 type IV collagenase in human brain tumors
22. Extracellular matrix remodelling and cellular differentiation
23. A 25 kDa a2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase
24. Loss of basement membrane type IV collagen is associated with increased expression of metalloprotease 2 and 9 (MMP-2 and MMP-9) during colorectal tumorigenesis
25. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer